跳至主要内容
临床试验/NCT01364701
NCT01364701Unknown4 期

A Prospective, Randomized, 3-arm Parallel Trial to Evaluate the Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i Treatment

Rambam Health Care Campus1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2011年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
30
试验地点
1
主要终点
International Index of Erectile Function-Erectile Dysfunction (IIEF-ED) Domain Score

研究概览

简要总结

Clinical effectiveness is of the finest tools to evaluate treatment success and is combined of 3 elements: treatment effectivity, side effect profile and patient compliance. Since the 3 main PDE5i's differ in their molecular structure, therapeutic profile and pharmacokinetics, it seems logical to assume that combining 2 different PDE5i's at lower dosage each may be beneficial in comparison to a single PDE5i maximal dose therapy. The aim of this study is to compare the clinical effectiveness of combination therapy (2 lower-dose PDE5i's) versus single maximal dose PDE5i therapy.

详细描述

This will be a prospective, randomized, 3-arm parallel trial on 60 males with erectile dysfunction (ED) that have never been exposed to PDE5i therapy (naïve patients) will be enrolled. In each group, every patient will receive three treatment regimes (Viagra®50mg & Cialis®10mg, Viagra®100mg, Cialis®20mg), in different sequences of administration.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ranging between 35-75 years.
  • Sexually active
  • IIEF ED domain score 22 and below

排除标准

  • Subjects with premature ejaculation as their main sexual complaint.
  • Subjects with severe cardiovascular disease
  • Subjects with Contraindications to PDE5i therapy. Namely patients receiving treatment with nitrate based medication or patients that for various reasons cannot take PDE5 inhibitors (i.e severe coronary disease, liver or renal failure, concomitant medications, etc.).

研究组 & 干预措施

Maximal dose sildenafil

Active Comparator

4 tablets of sildenafil 100mg are given for on demand use

干预措施: Sildenafil 100 mg (Drug)

Tadalafil 20mg maximal dose

Active Comparator

4 tablets of tadalafil 20mg are given for on demand use

干预措施: Tadalafil 20 mg (Drug)

Combination half dose

Active Comparator

4 tablets of sildenafil 50mg and tadalafil 10mg are given for on demand use

干预措施: Combination half of maximal dose for sildenafil & tadalafil (Drug)

结局指标

主要结局

International Index of Erectile Function-Erectile Dysfunction (IIEF-ED) Domain Score

时间窗: Every visit- altogether 3 months

At each visit after use of different treatment each time

次要结局

  • Erection Hardness Scale(Each visit- altogether 3 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验